Perimeter Medical Imaging AI (TSE:PINK) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Perimeter Medical Imaging AI has announced positive results from a clinical trial for its B-Series OCT system with ImgAssist AI 2.0, showing a significant reduction in residual cancer during breast-conserving surgeries compared to standard methods. This breakthrough could potentially lower reoperation rates and improve patient experiences, setting the stage for FDA approval in early 2025.
For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
